Tredje AP fonden Buys New Position in Option Care Health, Inc. $OPCH

Tredje AP fonden bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 36,683 shares of the company’s stock, valued at approximately $1,018,000.

A number of other hedge funds have also added to or reduced their stakes in the business. Swedbank AB bought a new position in Option Care Health during the third quarter worth $49,455,000. Boston Partners increased its stake in Option Care Health by 34.8% in the second quarter. Boston Partners now owns 952,299 shares of the company’s stock valued at $30,311,000 after purchasing an additional 245,990 shares in the last quarter. Aristides Capital LLC acquired a new position in shares of Option Care Health during the second quarter valued at about $249,000. Prudential Financial Inc. raised its holdings in shares of Option Care Health by 32.6% during the second quarter. Prudential Financial Inc. now owns 396,158 shares of the company’s stock valued at $12,867,000 after purchasing an additional 97,465 shares during the period. Finally, Pacer Advisors Inc. bought a new position in shares of Option Care Health during the 3rd quarter worth about $593,000. 98.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Stephens raised Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Citigroup reissued an “outperform” rating on shares of Option Care Health in a research note on Tuesday, January 13th. Weiss Ratings restated a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 29th. Jefferies Financial Group reaffirmed a “buy” rating and set a $37.00 target price on shares of Option Care Health in a research report on Tuesday, January 13th. Finally, Bank of America increased their target price on Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $37.58.

Option Care Health Stock Performance

Shares of Option Care Health stock opened at $35.69 on Monday. The company has a market cap of $5.67 billion, a PE ratio of 28.33, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. Option Care Health, Inc. has a 52 week low of $24.24 and a 52 week high of $36.80. The business has a 50 day moving average price of $33.92 and a 200-day moving average price of $30.41. The company has a quick ratio of 1.05, a current ratio of 1.56 and a debt-to-equity ratio of 0.85.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.